Stifel Maintains on InterMune
January 10, 2014 at 08:20 AM EST
In a report published Friday, Stifel analyst Stephen Willey maintained Buy on InterMune (NASDAQ: ITMN ), raising its price target from $20.00 to $23.00. According to the report, ITMN pre-announced a 4Q13 Esbriet beat and provided what appears to be fairly conservative FY14 Esbriet sales guidance ($115M-135M). Analysts continue
